한글목차

세계 누점 플러그 장치 시장 규모는 2024년에 7,838만 달러에 달했고, 2033년에는 1억 7,615만 달러에 달할 것으로 예상되며, 예측 기간인 2025-2033년에는 9.50%의 연평균 복합 성장률(CAGR)을 달성할 것으로 예상됩니다.

눈물길 플러그라고도 불리는 누점 플러그는 눈물의 배출을 차단하여 눈을 촉촉하게 하기 위해 누점(누점)에 삽입할 수 있는 작은 기구입니다. 누점은 눈꺼풀에 있는 작은 구멍으로, 눈물이 배출되는 곳입니다. 이 구멍을 막음으로써 눈물의 배출을 늦추거나 멈추게 하여 눈의 수분을 유지하고 안구건조증을 예방할 수 있습니다. 이 작은 마개가 눈물 배출 통로를 막음으로써 눈물이 눈 표면에 머물러 지속적인 윤활작용을 할 수 있습니다.

기술의 발전은 이러한 장치의 설계 방법을 개선하여 누점 플러그 장치 시장을 크게 촉진하고 있습니다. 모양이 바뀌는 플러그와 같은 새로운 디자인은 삽입을 용이하게 하고 눈물 차단 효과를 높이고 있습니다. 치료 계획에서 디지털 도구의 사용과 콜라겐 및 용해성 플러그와 같은 재료의 개발은 이러한 장치를 더욱 편안하게 만들고 합병증을 감소시키고 있습니다. 그 결과, 안구건조증을 치료하고, 눈물을 안정화시키고, 환자의 예후를 개선하기 위해 누점 플러그가 더욱 매력적인 선택이 되고 있습니다.

또한, 덱사메타손과 같은 약물 전달 시스템을 내장하여 약물 방출을 제어할 수 있도록 설계할 수도 있습니다. 흡수성 합성수지와 같은 재료의 혁신은 플러그가 떨어지거나 불편함을 유발하는 합병증을 줄이고, 용해 가능한 재료는 제거 절차의 필요성을 없애고 환자의 편안함과 순응도를 향상시킵니다. 따라서 위의 요인들이 시장 성장을 가속할 것으로 예상됩니다.

누점 플러그와 관련된 위험은 시장 성장을 저해할 것으로 예상됩니다. 위험에는 감염, 알레르기 반응, 플러그 압출 등이 있습니다. 기타 부작용으로는 눈물이 나거나, 플러그의 이탈, 드물게 화농성 육아종 및 천공 협착이 발생할 수 있습니다. 플러그가 눈물길로 이동하는 경우도 발생할 수 있으며, 이 경우 수술적 개입이 필요할 수 있습니다.

세계의 누점 플러그 디바이스 시장에 대해 조사했으며, 시장 개요와 함께 제품 유형별/재료별/적응증별/최종사용자별/지역별 동향, 경쟁 구도, 시장 진출 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 조사 방법과 범위

제2장 정의와 개요

제3장 주요 요약

제4장 시장 역학

• 영향요인
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석

제5장 전략적 인사이트와 업계 전망

• 시장 리더와 선구자
• CXO의 견해
• 최신 개발과 Break through
• 사례 연구/진행중인 조사
• 규제와 상환 상황
• Porter의 Five Forces 분석
• 공급망 분석
• 특허 분석
• SWOT 분석
• 미충족 요구와 갭
• 시장 진입 및 확장을 위한 권장 전략
• 시나리오 분석 : 베스트 케이스, 기본 케이스, 워스트 케이스 예측
• 가격 분석과 가격 동향
• 주요 업계 리더

제6장 제품 유형별

• 영구 누점 플러그
• 일시적 누점 플러그
• 반영구적 누점 플러그

제7장 재질별

• 실리콘
• 콜라겐
• 기타

제8장 적응증별

• 안구건조증
• 라식 수술 후 안구건조증
• 눈물흘림증(Epiphora)
• 기타

제9장 최종사용자별

• 병원
• 전문 클리닉
• 기타

제10장 지역별

• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 스페인
  • 이탈리아
  • 기타
• 남미
  • 브라질
  • 아르헨티나
  • 기타
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 한국
  • 기타
• 중동 및 아프리카

제11장 경쟁 구도

제12장 기업 개요

• Corza Medical
• FCI
• OASIS Medical, Inc.
• INNOVIA MEDICAL
• medennium Co., Ltd.
• Bernell Corporation.
• Diamatrix LTD.
• Ophtho India inc.
• Lacrivera
• Surtex Instruments Limited

제13장 부록

영문목차

The global punctal plug devices market reached US$ 78.38 million in 2024 and is expected to reach US$ 176.15 million by 2033, growing at a CAGR of 9.50% during the forecast period 2025-2033.

Punctal plugs, also called tear duct plugs or lacrimal plugs, are small devices that can be inserted into the tear ducts (puncta) to block tear drainage and keep the eyes moist. The puncta are small openings in the eyelids that allow tears to drain. By blocking these openings, punctal plugs slow or stop tear fluid from draining, helping to maintain eye moisture and prevent dry eyes. These tiny plugs block the tear drainage channel, allowing fluid to remain on the eye's surface for continuous lubrication.Market Dynamics: Drivers & Restraints

Increasing Technological Advancements

Technological advancements are significantly boosting the punctal plug devices market by improving how these devices are designed. New designs, like shape-shifting plugs, make them easier to insert and more effective at blocking tears. The use of digital tools in treatment planning, along with the development of materials like collagen and dissolvable plugs, is also making these devices more comfortable and reducing complications. As a result, punctal plugs are becoming a more attractive option for treating dry eye disease, stabilizing tear film, and improving patient outcomes.

Furthermore, punctal plugs can be designed with an inbuilt drug delivery system, such as dexamethasone for controlled drug release. Innovations in materials, like absorbable synthetics, reduce complications such as plugs falling out or causing discomfort, while dissolvable materials eliminate the need for removal procedures, enhancing patient comfort and compliance. Thus, the above factors are expected to drive the market growth.

Risks Associated with the Punctal Plugs

Risks associated with the punctal plugs are expected to hinder market growth. The risks include infection, allergic reactions, and plug extrusion. Other side effects include watery eyes, plug displacement, and, in rare cases, the development of pyogenic granuloma or punctal stenosis. Migration of the plug into the lacrimal drainage system may also occur, potentially requiring surgical intervention.

Segment Analysis

The global punctal plug devices market is segmented based on type, material, indication, end-user, and region.

Treatment:

Temporary punctal plugs segment is expected to dominate the global Punctal Plug Devices market share

Temporary punctal plugs are a popular choice in the punctal plug devices market, especially in North America and Europe, because they are minimally invasive and comfortable for patients. Since these plugs dissolve on their own, there's no need for a removal procedure, which makes them more convenient for patients.

These plugs also give healthcare providers more flexibility in managing treatment and tailoring it to each patient's needs. Additionally, temporary plugs are a cost-effective option and offer short-term relief from dry eye symptoms, particularly after LASIK surgery. A key advantage is that they allow patients to try out punctal occlusion without committing to a permanent solution. For instance, in April 2024, Oasis Medical launched the SOFT PLUG Extended Duration 180-T Tapered Plug, a new solution for treating dry eye syndrome. The plug is designed with a 0.25mm tapered end for easier insertion into the punctal opening and is made from degradable polydioxanone monofilament. It is intended to temporarily block tear drainage and treat dry eye syndrome and related ocular surface diseases. The plug degrades in approximately 180 days, eliminating the need for manual removal.

Geographical Analysis

North America is expected to hold a significant position in the global punctal plug devices market share

North America's leading position in the punctal plug devices market is attributed to several key factors. The region has a well-developed healthcare system and a high number of people suffering from dry eye syndrome, which increases the need for treatments like punctal plugs. For instance, according to the Between 16.7 million and 50.2 million Americans, or 5-15% of the population, currently have dry eyes, and the condition costs the U.S. economy over $55.4 billion annually. Approximately 20 million people in the United States (344 million people worldwide) have dry eye disease (DED), and that number is growing. The prevalence of dry eye varies, with studies reporting figures ranging from 5% to as high as 73.5%.

The region also readily embraces advanced eye care technologies, and there's a strong awareness of eye health among patients and healthcare professionals. Higher incomes and greater spending on healthcare in North America mean more people can access and use punctal plug devices.

Competitive Landscape

The major global players in the punctal plug devices market include Corza Medical, FCI, OASIS Medical, Inc., INNOVIA MEDICAL, medennium Co., Ltd., Bernell Corporation., Diamatrix LTD., Ophtho India Inc., Lacrivera and Surtex Instruments Limited among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Punctal Plug Devices Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Type
• 3.2. Snippet by Material
• 3.3. Snippet by Indication
• 3.4. Snippet by End-User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Technological Advancements
  • 4.1.2. Restraints
    • 4.1.2.1. Risks Associated with the Punctal Plugs
  • 4.1.3. Opportunity
• 4.2. Impact Analysis

5. Strategic Insights and Industry Outlook

• 5.1. Market Leaders and Pioneers
  • 5.1.1. Emerging Pioneers and Prominent Players
  • 5.1.2. Established leaders with largest selling Brand
  • 5.1.3. Market leaders with established Product
• 5.2. CXO Perspectives
• 5.3. Latest Developments and Breakthroughs
• 5.4. Case Studies/Ongoing Research
• 5.5. Regulatory and Reimbursement Landscape
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa
• 5.6. Porter's Five Force Analysis
• 5.7. Supply Chain Analysis
• 5.8. Patent Analysis
• 5.9. SWOT Analysis
• 5.10. Unmet Needs and Gaps
• 5.11. Recommended Strategies for Market Entry and Expansion
• 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 5.13. Pricing Analysis and Price Dynamics
• 5.14. Key Opinion Leaders

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Permanent Punctal Plugs*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Temporary Punctal Plugs
• 6.4. Semi-Permanent Punctal Plugs

7. By Material

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 7.1.2. Market Attractiveness Index, By Material
• 7.2. Silicone*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Collagen
• 7.4. Others

8. By Indication

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 8.1.2. Market Attractiveness Index, By Indication
• 8.2. Dry Eye Syndrome*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Post-LASIK Induced Dry Eye
• 8.4. Epiphora
• 8.5. Others

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Specialty Clinics
• 9.4. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. U.K.
    • 10.3.7.3. France
    • 10.3.7.4. Spain
    • 10.3.7.5. Italy
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. South Korea
    • 10.5.7.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

• 12.1. Corza Medical*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio
    • 12.1.2.1. Product Description
    • 12.1.2.2. Product Key Performance Indicators (KPIs)
    • 12.1.2.3. Historic and Forecasted Product Sales
    • 12.1.2.4. Product Sales Volume
  • 12.1.3. Financial Overview
    • 12.1.3.1. Company Revenue's
    • 12.1.3.2. Geographical Revenue Shares
    • 12.1.3.3. Revenue Forecasts
  • 12.1.4. Key Developments
    • 12.1.4.1. Mergers & Acquisitions
    • 12.1.4.2. Key Product Development Activities
    • 12.1.4.3. Regulatory Approvals etc.
  • 12.1.5. SWOT Analysis
• 12.2. FCI
• 12.3. OASIS Medical, Inc.
• 12.4. INNOVIA MEDICAL
• 12.5. medennium Co., Ltd.
• 12.6. Bernell Corporation.
• 12.7. Diamatrix LTD.
• 12.8. Ophtho India inc.
• 12.9. Lacrivera
• 12.10. Surtex Instruments Limited
• Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us